Your browser doesn't support javascript.
loading
Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.
Creary, Lisa E; Guerra, Sandra G; Chong, Winnie; Brown, Colin J; Turner, Thomas R; Robinson, James; Bultitude, Will P; Mayor, Neema P; Marsh, Steven G E; Saito, Katsuyuki; Lam, Kevin; Duke, Jamie L; Mosbruger, Timothy L; Ferriola, Deborah; Monos, Dimitrios; Willis, Amanda; Askar, Medhat; Fischer, Gottfried; Saw, Chee Loong; Ragoussis, Jiannis; Petrek, Martin; Serra-Pagés, Carles; Juan, Manel; Stavropoulos-Giokas, Catherine; Dinou, Amalia; Ameen, Reem; Al Shemmari, Salem; Spierings, Eric; Gendzekhadze, Ketevan; Morris, Gerald P; Zhang, Qiuheng; Kashi, Zahra; Hsu, Susan; Gangavarapu, Sridevi; Mallempati, Kalyan C; Yamamoto, Fumiko; Osoegawa, Kazutoyo; Vayntrub, Tamara; Chang, Chia-Jung; Hansen, John A; Fernández-Vina, Marcelo A.
Afiliación
  • Creary LE; Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA; Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA. Electronic address: lcreary@stanford.edu.
  • Guerra SG; Histocompatibility and Immunogenetics Service Development Laboratory, NHS Blood and Transplant, London, UK.
  • Chong W; Histocompatibility and Immunogenetics Service Development Laboratory, NHS Blood and Transplant, London, UK.
  • Brown CJ; Department of Histocompatibility and Immunogenetics, NHS Blood and Transplant, London, UK.
  • Turner TR; Anthony Nolan Research Institute, Royal Free Hospital, London, UK; UCL Cancer Institute, Royal Free Campus, London, UK.
  • Robinson J; Anthony Nolan Research Institute, Royal Free Hospital, London, UK; UCL Cancer Institute, Royal Free Campus, London, UK.
  • Bultitude WP; Anthony Nolan Research Institute, Royal Free Hospital, London, UK; UCL Cancer Institute, Royal Free Campus, London, UK.
  • Mayor NP; Anthony Nolan Research Institute, Royal Free Hospital, London, UK; UCL Cancer Institute, Royal Free Campus, London, UK.
  • Marsh SGE; Anthony Nolan Research Institute, Royal Free Hospital, London, UK; UCL Cancer Institute, Royal Free Campus, London, UK.
  • Saito K; Molecular Biology Research Department, One Lambda, Thermo Fisher Scientific, Canoga Park, CA, USA.
  • Lam K; Molecular Biology Research Department, One Lambda, Thermo Fisher Scientific, Canoga Park, CA, USA.
  • Duke JL; Immunogenetics Laboratory, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Mosbruger TL; Immunogenetics Laboratory, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Ferriola D; Immunogenetics Laboratory, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Monos D; Immunogenetics Laboratory, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology and Lab Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Willis A; Department of Pathology and Laboratory Medicine, Baylor University Medical Center, Dallas, USA.
  • Askar M; Department of Pathology and Laboratory Medicine, Baylor University Medical Center, Dallas, USA.
  • Fischer G; Department for Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
  • Saw CL; HLA Laboratory, Division of Haematology, McGill University Health Centre, Montreal, Canada.
  • Ragoussis J; Department of Human Genetics, McGill University & McGill University and Genome Quèbec Innovation Centre, Montreal, Canada.
  • Petrek M; Department of Pathological Physiology and Immunogenomics, IMTM, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
  • Serra-Pagés C; Immunology Department, Hospital Clinic de Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain.
  • Juan M; Immunology Department, Hospital Clinic de Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain.
  • Stavropoulos-Giokas C; Biomedical Research Foundation Academy of Athens, Hellenic Cord Blood Bank, Athens, Greece.
  • Dinou A; Biomedical Research Foundation Academy of Athens, Hellenic Cord Blood Bank, Athens, Greece.
  • Ameen R; Health Sciences Center, Kuwait University, Kuwait.
  • Al Shemmari S; Health Sciences Center, Kuwait University, Kuwait.
  • Spierings E; Laboratory of Translational Immunology, UMC Utrecht, Utrecht, Netherlands.
  • Gendzekhadze K; HLA Laboratory, City of Hope, Duarte, CA, USA.
  • Morris GP; Department of Pathology, University of California San Diego, La Jolla, CA, USA.
  • Zhang Q; Department of Pathology and Laboratory Medicine, UCLA Immunogenetics Center, Los Angeles, CA, USA.
  • Kashi Z; HLA Department, Kashi Clinical Laboratories, Inc., Portland, OR, USA.
  • Hsu S; HLA Laboratory, American Red Cross, Philadelphia, PA, USA.
  • Gangavarapu S; Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.
  • Mallempati KC; Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.
  • Yamamoto F; Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.
  • Osoegawa K; Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.
  • Vayntrub T; Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.
  • Chang CJ; Stanford Genome Technology Center, Palo Alto, CA, USA.
  • Hansen JA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Fernández-Vina MA; Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA; Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.
Hum Immunol ; 80(7): 449-460, 2019 Jul.
Article en En | MEDLINE | ID: mdl-30844424
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Prueba de Histocompatibilidad / Linfocitos B / Antígenos de Histocompatibilidad Clase I / Antígenos de Histocompatibilidad Clase II / Herpesvirus Humano 4 / Antígenos HLA Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Hum Immunol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Prueba de Histocompatibilidad / Linfocitos B / Antígenos de Histocompatibilidad Clase I / Antígenos de Histocompatibilidad Clase II / Herpesvirus Humano 4 / Antígenos HLA Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Hum Immunol Año: 2019 Tipo del documento: Article